Forte Biosciences, Inc.

NASDAQ:FBRX

Biotechnology

Healthcare
$76.99 +1.71%

+$0.30 today

Market cap
$1.58B
Beta
2.87
P/E (TTM)
-42.1
EPS (TTM)
-$0.43
52W Low $9.10High $35.80

Volume 0.00M

Average 0.30M

Balance Sheet

Inspect the capital base behind the business.

Assets

$82.78M

FY 2025 · Annual

+34.5% YoY

Liabilities

$21.79M

FY 2025 · Annual

+139.9% YoY

Equity

$60.99M

FY 2025 · Annual

+16.2% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents42.04M41.1M11.96M22.24M76.96M
Short-term Investments0025.16M36.12M0
Net Receivables0000817K
Inventory00000
Other Current Assets89K70K165K336K422K
Total Current Assets42.52M41.51M38.33M61.35M80.59M
Property, Plant & Equipment (Net)00109K77K129K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets786K486K544K138K2.06M
Total Non-current Assets786K486K653K215K2.19M
Total Assets43.31M42M38.98M61.56M82.78M
Account Payables946K1.15M1.42M4.88M9.99M
Short-term Debt00000
Tax Payables00001.04M
Deferred Revenue00000
Other Current Liabilities681K890K947K1.55M2.25M
Total Current Liabilities1.76M3.18M3.67M9.08M20.75M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00001.04M
Total Non-current Liabilities00001.04M
Total Liabilities1.76M3.18M3.67M9.08M21.79M
Common Stock15K21K36K6K13K
Retained Earnings(73.17M)(87.04M)(118.52M)(154M)(223.37M)
Accumulated OCI(43.31M)04K11K3K
Other Stockholders Equity00000
Minority Interest00000
Total Equity41.55M38.82M35.31M52.48M60.99M
Total Debt00000
Net Debt(42.04M)(41.1M)(11.96M)(22.24M)(76.96M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$58.2M
Receivables$655.0K
Other Current$6.2M
Total Current Assets$65.1M
PP&E (Net)$110.0K
Other Non-current$2.0M
Total Non-current Assets$2.1M
Total Assets$67.2M

Analysis

Selected assets total $67.2M for Latest. The largest visible component is Cash & Equivalents at $58.2M, about 86.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 14D9/ASC 14D9/A filingAug 21, 2026
SC TO-T/ASC TO-T/A filingAug 19, 2026
SC 14D9/ASC 14D9/A filingAug 19, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 13, 2026

How much cash does FBRX have?

Forte Biosciences, Inc. (FBRX) reported $76.96M in cash and equivalents in fiscal 2025.

How much debt does FBRX carry?

Forte Biosciences, Inc. (FBRX) reported $0.00 of total debt, with net debt of -$76.96M.